Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine

被引:47
作者
Anwer, K [1 ]
Shi, M [1 ]
French, MF [1 ]
Muller, SR [1 ]
Chen, W [1 ]
Liu, QS [1 ]
Proctor, BL [1 ]
Wang, JJ [1 ]
Mumper, RJ [1 ]
Singhal, A [1 ]
Rolland, AP [1 ]
Alila, HW [1 ]
机构
[1] GeneMed Inc, The Woodlands, TX 77381 USA
关键词
D O I
10.1089/hum.1998.9.5-659
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
A muscle-specific gene medicine is described that provides for long-term secretion of biologically active human growth hormone (hGH) from skeletal muscle into the systemic circulation. The hGH gene medicine is composed of a muscle-specific hGH plasmid expression system complexed with a protective, interactive, noncondensing (PINC(TM)) delivery system. The muscle-specific gene expression system, pSK-hGH-GH, was constructed by linking the promoter/enhancer regions of chicken skeletal alpha-actin to hGH gene. C2C12 myoblast transfection with pSK-hGH-GH resulted in the synthesis of hGH in a muscle-specific manner. Direct injection into rat tibialis cranialis muscle of pSK-hGH-GH complexed with a polymeric PINC delivery system, polyvinylpyrrolidone (PVP), produced hGH levels in muscle that were 10- to 15-fold higher compared with plasmid formulated in saline at 14 days post-injection. Intratracheal instillation in rat lung of pSK-hGH-GH did not produce significantly detectable levels of hGH. In hypophysectomized rats, a single intramuscular dose of the pSK-hGH-GH/PVP complex resulted in hGH expression and a subsequent increase in serum levels of rat ICE-I and growth. hCH expression and effects on rat serum ICE-I levels were detectable up to 28 days after injection of formulated plasmid and effects on growth were detectable unto 21 days. Anti-hGH antibodies were detectable in serum at 14 days post-injection, reached a plateau at 21 days, and remained elevated through the study period. Cyclosporin treatment of the pSK-hGH-GH/PVP-injected animals completely inhibited the antibody response and resulted in increased hGH expression.
引用
收藏
页码:659 / 670
页数:12
相关论文
共 37 条
[1]
Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats [J].
Alila, H ;
Coleman, M ;
Nitta, H ;
French, M ;
Anwer, K ;
Liu, QS ;
Meyer, T ;
Wang, JJ ;
Mumper, R ;
Oubari, D ;
Long, S ;
Nordstrom, J ;
Rolland, A .
HUMAN GENE THERAPY, 1997, 8 (15) :1785-1795
[2]
EXPRESSION OF ACTIVE HUMAN CLOTTING FACTOR-IX FROM RECOMBINANT DNA CLONES IN MAMMALIAN-CELLS [J].
ANSON, DS ;
AUSTEN, DEG ;
BROWNLEE, GG .
NATURE, 1985, 315 (6021) :683-685
[3]
GROWTH-HORMONE CONTROL OF TISSUE PROTEIN-METABOLISM IN DWARF MICE - ENHANCEMENT BY A MONOCLONAL-ANTIBODY [J].
BATES, PC ;
ASTON, R ;
HOLDER, AT .
JOURNAL OF ENDOCRINOLOGY, 1992, 132 (03) :369-375
[4]
DELIMITATION AND CHARACTERIZATION OF CIS-ACTING DNA-SEQUENCES REQUIRED FOR THE REGULATED EXPRESSION AND TRANSCRIPTIONAL CONTROL OF THE CHICKEN SKELETAL ALPHA-ACTIN GENE [J].
BERGSMA, DJ ;
GRICHNIK, JM ;
GOSSETT, LMA ;
SCHWARTZ, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (07) :2462-2475
[5]
BRENNAN KJ, 1993, J BIOL CHEM, V268, P719
[6]
MOLECULAR-BASIS OF MYOTONIC-DYSTROPHY - EXPANSION OF A TRINUCLEOTIDE (CTG) REPEAT AT THE 3' END OF A TRANSCRIPT ENCODING A PROTEIN-KINASE FAMILY MEMBER [J].
BROOK, JD ;
MCCURRACH, ME ;
HARLEY, HG ;
BUCKLER, AJ ;
CHURCH, D ;
ABURATANI, H ;
HUNTER, K ;
STANTON, VP ;
THIRION, JP ;
HUDSON, T ;
SOHN, R ;
ZEMELMAN, B ;
SNELL, RG ;
RUNDLE, SA ;
CROW, S ;
DAVIES, J ;
SHELBOURNE, P ;
BUXTON, J ;
JONES, C ;
JUVONEN, V ;
JOHNSON, K ;
HARPER, PS ;
SHAW, DJ ;
HOUSMAN, DE .
CELL, 1992, 68 (04) :799-808
[7]
MYOGENIC VECTOR EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I STIMULATES MUSCLE-CELL DIFFERENTIATION AND MYOFIBER HYPERTROPHY IN TRANSGENIC MICE [J].
COLEMAN, ME ;
DEMAYO, F ;
YIN, KC ;
LEE, HM ;
GESKE, R ;
MONTGOMERY, C ;
SCHWARTZ, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :12109-12116
[8]
GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J].
DAI, Y ;
ROMAN, M ;
NAVIAUX, RK ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10892-10895
[9]
DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[10]
DIRECT GENE-TRANSFER IN SKELETAL-MUSCLE - PLASMID DNA-BASED IMMUNIZATION AGAINST THE HEPATITIS-B VIRUS SURFACE-ANTIGEN [J].
DAVIS, HL ;
MICHEL, ML ;
MANCINI, M ;
SCHLEEF, M ;
WHALEN, RG .
VACCINE, 1994, 12 (16) :1503-1509